List of Studies ( Metabolite:N-Butyryl-L-homoserine lactone)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004190 | AN006962 | Comparative Analysis of the Metabolic Profiles of Alix−/− and Ozz−/− Soleus Skeletal Muscle | Muscle | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST003896 | AN006399 | Postprandial Plasma Metabolomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal | Blood | Human | Cardiovascular disease | Nanjing Medical University | Other |
| ST003896 | AN006399 | Postprandial Plasma Metabolomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal | Blood | Human | Diabetes | Nanjing Medical University | Other |
| ST003896 | AN006399 | Postprandial Plasma Metabolomic Changes in 147 Individuals Following Ingestion of a Standard Mixed Meal | Blood | Human | Obesity | Nanjing Medical University | Other |
| ST003895 | AN006398 | Postprandial Plasma Metabolomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients | Blood | Human | Cardiovascular disease | Nanjing Medical University | Other |
| ST003895 | AN006398 | Postprandial Plasma Metabolomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients | Blood | Human | Diabetes | Nanjing Medical University | Other |
| ST003895 | AN006398 | Postprandial Plasma Metabolomic Changes in 24 Metabolically Healthy Individuals Following Ingestion of Four Different Isocaloric Macronutrients | Blood | Human | Obesity | Nanjing Medical University | Other |
| ST003778 | AN006205 | Human to mouse microbiota transfer model demonstrates disease-modifying effects of the short-chain fatty acid biotherapy modified microbiota | Feces | Mouse | Diabetes | University of Queensland | LC-MS |
| ST003778 | AN006206 | Human to mouse microbiota transfer model demonstrates disease-modifying effects of the short-chain fatty acid biotherapy modified microbiota | Feces | Mouse | Diabetes | University of Queensland | LC-MS |
| ST003053 | AN005006 | Providing insight into the mechanism of action of Cationic Lipidated Oligomers (CLOs) using metabolomics | Bacterial cells | Staphylococcus aureus | Bacterial infection | Monash University | LC-MS |
| ST002776 | AN004519 | Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002775 | AN004517 | Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST002551 | AN004200 | Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST002405 | AN003919 | Stool global metabolite levels in peanut allergy (Part 2) | Feces | Human | Peanut allergy | Icahn School of Medicine at Mount Sinai | LC-MS |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | LC-MS |
| ST001788 | AN002899 | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Macrophages | Human | Monash University | LC-MS | |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001175 | AN001950 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000539 | AN000819 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash University | LC-MS | |
| ST000403 | AN000643 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences | LC-MS |